NEW YORK (Reuters) - Johnson & Johnson <JNJ.N> has agreed to pay $22.9 million to end a lawsuit from investors who claimed the company concealed quality-control failures that culminated in a broad recall of children's medicines, according to court filings. Full story
During a conference call Tuesday to review Johnson & Johnson's second-quarter results, analysts asked about ongoing work to fix manufacturing deficiencies in the consumer health business that have resulted in most of the four dozen product recalls by the company since September 2009. Full story
STRONG RESULTS: Johnson & Johnson's second-quarter net income more than doubled. Its adjusted net income jumped 18 percent to $4.29 billion, or $1.48 per share. Revenue was $17.88 billion, up 8.5 percent. Both topped analysts' expectations. Full story
Among the earnings stories for Tuesday, July 16, from AP Business News: Full story
Johnson & Johnson and JMP are each up more than 25 percent this year. Should you buy stocks you know? CNBC's Jim Cramer and Herb Greenberg discuss.
CNBC's Melissa Lee, Herb Greenberg and Kayla Tausche dissect the numbers on Coca-Cola's disappointing quarter, Goldman Sach's big beat, Johnson & Johnson's new record high, and Yahoo! after the bell.
The "Squawk on the Street" news team reports on today's top business headlines, including this morning's earnings result for Goldman Sachs, Coca-Cola and Johnson & Johnson.
Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell. Today Cramer provides his take on Johnson & Johnson, Goldman Sachs and Coca-Cola's earnings.
A look at what's driving earnings at Coca-Cola and Johnson & Johnson, with Tom Anderson, Boston Private Bank.
Products made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado in this April 14, 2009 file photo. Johnson & Johnson reported higher-than-expected second quarter earnings as strong sales of prescription drugs and medical devises more than offset anemic growth of its consumer pr
A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado April 14, 2009. REUTERS/Rick Wilking
Products made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado in this April 14, 2009, file photo. Johnson & Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that had be